No Data
Earnings Preview: PRCT to Report Financial Results Pre-market on April 24
Investors Appear Satisfied With PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) Prospects
Piper Sandler Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Maintains Target Price $100
PROCEPT BioRobotics | 10-K/A: Annual report (Amendment)
Truist Financial Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Cuts Target Price to $70
PROCEPT BioRobotics Analyst Ratings
Tesla 1st : Agreed